148 related articles for article (PubMed ID: 20083278)
1. Variations among experienced surgeons in cancer control after open radical prostatectomy.
Bianco FJ; Vickers AJ; Cronin AM; Klein EA; Eastham JA; Pontes JE; Scardino PT
J Urol; 2010 Mar; 183(3):977-82. PubMed ID: 20083278
[TBL] [Abstract][Full Text] [Related]
2. Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center.
Vickers A; Savage C; Bianco F; Mulhall J; Sandhu J; Guillonneau B; Cronin A; Scardino P
Eur Urol; 2011 Mar; 59(3):317-22. PubMed ID: 21095055
[TBL] [Abstract][Full Text] [Related]
3. The surgical learning curve for prostate cancer control after radical prostatectomy.
Vickers AJ; Bianco FJ; Serio AM; Eastham JA; Schrag D; Klein EA; Reuther AM; Kattan MW; Pontes JE; Scardino PT
J Natl Cancer Inst; 2007 Aug; 99(15):1171-7. PubMed ID: 17652279
[TBL] [Abstract][Full Text] [Related]
4. Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.
Klein EA; Bianco FJ; Serio AM; Eastham JA; Kattan MW; Pontes JE; Vickers AJ; Scardino PT
J Urol; 2008 Jun; 179(6):2212-6; discussion 2216-7. PubMed ID: 18423716
[TBL] [Abstract][Full Text] [Related]
5. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC
J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve Study.
Bravi CA; Tin A; Vertosick E; Mazzone E; Martini A; Dell'Oglio P; Stabile A; Gandaglia G; Fossati N; Suardi N; Gallina A; Briganti A; Montorsi F; Vickers A
J Urol; 2019 Jul; 202(1):108-113. PubMed ID: 30747873
[TBL] [Abstract][Full Text] [Related]
7. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
[TBL] [Abstract][Full Text] [Related]
8. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
Haese A; Huland E; Graefen M; Hammerer P; Noldus J; Huland H
J Urol; 1999 Apr; 161(4):1206-11. PubMed ID: 10081870
[TBL] [Abstract][Full Text] [Related]
9. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
Eastham JA; Kattan MW; Riedel E; Begg CB; Wheeler TM; Gerigk C; Gonen M; Reuter V; Scardino PT
J Urol; 2003 Dec; 170(6 Pt 1):2292-5. PubMed ID: 14634399
[TBL] [Abstract][Full Text] [Related]
10. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
11. Editorial comment.
Porter MP
J Urol; 2010 Mar; 183(3):982; discussion 983. PubMed ID: 20083274
[No Abstract] [Full Text] [Related]
12. Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.
Vickers AJ; Bianco FJ; Gonen M; Cronin AM; Eastham JA; Schrag D; Klein EA; Reuther AM; Kattan MW; Pontes JE; Scardino PT
Eur Urol; 2008 May; 53(5):960-6. PubMed ID: 18207316
[TBL] [Abstract][Full Text] [Related]
13. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.
Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD
BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548
[TBL] [Abstract][Full Text] [Related]
15. Determining When to Stop Prostate Specific Antigen Monitoring after Radical Prostatectomy: the Role of Ultrasensitive Prostate Specific Antigen.
Matsumoto K; Komatsuda A; Yanai Y; Niwa N; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Oya M
J Urol; 2017 Mar; 197(3 Pt 1):655-661. PubMed ID: 27590477
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
Sakai I; Harada K; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Inoue TA; Miyake H
Urol Int; 2006; 76(3):227-31. PubMed ID: 16601384
[TBL] [Abstract][Full Text] [Related]
17. Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?
Toussi A; Stewart-Merrill SB; Boorjian SA; Psutka SP; Thompson RH; Frank I; Tollefson MK; Gettman MT; Carlson RE; Rangel LJ; Karnes RJ
J Urol; 2016 Jun; 195(6):1754-9. PubMed ID: 26721226
[TBL] [Abstract][Full Text] [Related]
18. Prostate Specific Antigen Testing after Radical Prostatectomy-Can We Stop at 20 Years?
Ludwig WW; Feng Z; Trock BJ; Humphreys E; Walsh PC
J Urol; 2018 Jan; 199(1):114-119. PubMed ID: 28818527
[TBL] [Abstract][Full Text] [Related]
19. Effects of surgeon variability on oncologic and functional outcomes in a population-based setting.
Carlsson S; Berglund A; Sjoberg D; Khatami A; Stranne J; Bergdahl S; Lodding P; Aus G; Vickers A; Hugosson J
BMC Urol; 2014 Mar; 14():25. PubMed ID: 24602348
[TBL] [Abstract][Full Text] [Related]
20. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
